Alerts will be sent to your verified email
Verify Email
ZENITHDRUG
|
Zenith Drugs
|
Samrat Pharmachem
|
Amwill Health Care
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
22.97 % | 20.36 % | 84.18 % |
|
5yr average Equity Multiplier
|
4.46 | 1.97 | 0.32 |
|
5yr Average Asset Turnover Ratio
|
1.16 | 2.61 | 2.35 |
|
5yr Avg Net Profit Margin
|
4.99 % | 3.99 % | 13.8 % |
|
Price to Book
|
0.0 | 1.46 | 1.72 |
|
P/E
|
11.67 | 14.71 | 11.08 |
|
5yr Avg Cash Conversion Cycle
|
-99.3 Days | 59.17 Days | 115.9 Days |
|
Inventory Days
|
53.1 Days | 27.69 Days | 26.46 Days |
|
Days Receivable
|
141.66 Days | 78.39 Days | 133.46 Days |
|
Days Payable
|
298.39 Days | 45.36 Days | 129.03 Days |
|
5yr Average Interest Coverage Ratio
|
4.04 | 14.72 | 0.0 |
|
5yr Avg ROCE
|
30.01 % | 30.03 % | 102.76 % |
|
5yr Avg Operating Profit Margin
|
9.39 % | 5.83 % | 17.69 % |
|
5 yr average Debt to Equity
|
1.14 | 0.26 | 0.0 |
|
5yr CAGR Net Profit
|
25.02 % | -12.62 % | 33.09 % |
|
5yr Average Return on Assets
|
5.56 % | 10.58 % | 26.84 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
69.98 % | 49.09 % | 70.65 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -0.56 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Zenith Drugs
|
Samrat Pharmachem
|
Amwill Health Care
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|
Location Wise Break-Up
|
|
Distribution Channel
|
Distribution Channel
|
-
|
-
|